Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New chip promising for tumor-targeting research

23.09.2014

Researchers have developed a chip capable of simulating a tumor's "microenvironment" and plan to use the new system to test the effectiveness of nanoparticles and drugs that target cancer.

The new system, called a tumor-microenvironment-on-chip (T-MOC) device, will allow researchers to study the complex environment surrounding tumors and the barriers that prevent the targeted delivery of therapeutic agents, said Bumsoo Han, a Purdue University associate professor of mechanical engineering.


This illustration shows the design of a new chip capable of simulating a tumor's "microenvironment" to test the effectiveness of nanoparticles and drugs that target cancer. The new system, called a tumor-microenvironment-on-chip device, will allow researchers to study the complex environment surrounding tumors and the barriers that prevent the targeted delivery of therapeutic agents. (Purdue University photo/Altug Ozcelikkale, Bumsoo Han)

Researchers are trying to perfect "targeted delivery" methods using various agents, including an assortment of tiny nanometer-size structures, to selectively attack tumor tissue.

One approach is to design nanoparticles small enough to pass through pores in blood vessels surrounding tumors but too large to pass though the pores of vessels in healthy tissue. The endothelial cells that make up healthy blood vessels are well organized and have small pores in the tight junctions between them. However, the endothelial cells in blood vessels around tumors are irregular and misshapen, with larger pores in the gaps between the cells.

"It was thought that if nanoparticles were designed to be the right size they could selectively move toward only the tumor," Han said. 

However, one complication hindering the success of this strategy is that the pressure of "interstitial fluid" inside tumors is greater than that of surrounding healthy tissue. This greater pressure pushes out most drug-delivery and imaging agents, with only a small percentage of them reaching the target tumor.

Now, new research findings suggest that the T-MOC system is capable of simulating the complex environment around tumors and providing detailed information about how nanoparticles move through this environment. Such information could aid efforts to perfect targeted delivery methods.

The findings are detailed in a research paper appearing online this month and will be published in a print edition of the Journal of Controlled Release in November. The paper was authored by postdoctoral research associate Bongseop Kwak; graduate students Altug Ozcelikkale and Crystal S. Shin; Kinam Park, the Showalter Distinguished Professor of Biomedical Engineering and a professor of pharmaceutics; and Han.

The T-MOC chip is about 4.5 centimeters (1.8 inches) square and contains "microfluidic" channels where tumor cells and endothelial cells are cultured. The chip also incorporates extracellular matrix – a spongy, scaffold-like material made of collagen found between cells in living tissue.

The new chip offers an alternative to conventional experimental methods. Studies using cancer cells in petri plates exclude the complex microenvironment surrounding tumors, and research with animals does not show precisely how proposed therapies might work in people.

However, the T-MOC system has the potential to mimic cancer in humans, Han said.

The researchers tested the technology using human breast cancer and endothelial cells and studied how nanoparticles moved within the microenvironment.

Future work will expand to the study of anticancer drugs. Eventually, the devices might be used to grow tumor cells from patients to gauge the effectiveness of specific drugs in those people.

The work is based at the Birck Nanotechnology Center in Purdue's Discovery Park. It was supported by the National Science Foundation, National Institutes of Health, and a Collaboration in Translational Research Award from the Indiana Clinical and Translational Sciences Institute. Han's work also been supported by the B.S.F. Schaefer Award, the Discovery Park Fellowship, and an Incentive Grant Program from Purdue. 

Writer: Emil Venere, 765-494-4709, venere@purdue.edu 

Source: Bumsoo Han, 765-494-5626, bumsoo@purdue.edu 

ABSTRACT

Simulation of Complex Transport of Nanoparticles around a Tumor Using Tumor- Microenvironment-on-Chip      

Bongseop Kwak, Altug Ozcelikkale, Crystal S Shin, Kinam Park, and  Bumsoo Han  

Purdue University  

Delivery of therapeutic agents selectively to tumor tissue, which is referred as "targeted delivery," is one of the most ardently pursued goals of cancer therapy. Recent advances in nanotechnology enable numerous types of nanoparticles (NPs) whose properties can be designed for targeted delivery to tumors. In spite of promising early results, the delivery and therapeutic efficacy of the majority of NPs are still quite limited. This is mainly attributed to the limitation of currently available tumor models to test these NPs and systematically study the effects of complex transport and pathophysiological barriers around the tumors. In this study, thus, we developed a new in vitro tumor model to recapitulate the tumor microenvironment determining the transport around tumors. This model, named tumor-microenvironment-on-chip (T-MOC), consists of 3-dimensional microfluidic channels where tumor cells and endothelial cells are cultured within extracellular matrix under perfusion of interstitial fluid. Using this T-MOC platform, the transport of NPs and its variation due to tumor microenvironmental parameters have been studied including cut-off pore size, interstitial fluid pressure, and tumor tissue microstructure. The results suggest that T-MOC is capable of simulating the complex transport around the tumor, and providing detailed information about NP transport behavior. This finding confirms that NPs should be designed considering their dynamic interactions with tumor microenvironment.

Emil Venere | Eurek Alert!
Further information:
http://www.purdue.edu/newsroom/releases/2014/Q3/new-chip-promising-for-tumor-targeting-research.html

More articles from Medical Engineering:

nachricht UTSA study describes new minimally invasive device to treat cancer and other illnesses
02.12.2016 | University of Texas at San Antonio

nachricht Earlier Alzheimer's diagnosis may be possible with new imaging compound
02.11.2016 | Washington University School of Medicine

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>